Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

Cuzick Jack and Sestak Ivana and Forbes John F. and Dowsett Mitch and Knox Jill and Cawthorn Simon and Saunders Christobel and Roche Nicola and Mansel Robert E. and Minckwitz, von Gunter and Bonanni Bernardo and Palva Tiina and Howell Anthony and IBIS-II investigators and Kahán Zsuzsanna (kollab. közrem.): Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
LANCET, 383 (9922). pp. 1041-1048. ISSN 0140-6736 (2014)

[thumbnail of 1_s2.0_S0140673613622928_main_u.pdf]
Preview
Text
1_s2.0_S0140673613622928_main_u.pdf - Published Version

Download (462kB) | Preview
Item Type: Journal Article
Journal or Publication Title: LANCET
Date: 2014
Volume: 383
Number: 9922
Page Range: pp. 1041-1048
ISSN: 0140-6736
Publisher: The Lancet Publishing Group
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 2992640
DOI azonosító: https://doi.org/10.1016/S0140-6736(13)62292-8
Date Deposited: 2017. Sep. 18. 10:04
Last Modified: 2020. Feb. 21. 10:52
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11952
Web of Science® Times Cited: 326 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year